Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Biosimilars: SOP for Agarose Gel Electrophoresis – V 2.0

Posted on By


Biosimilars: SOP for Agarose Gel Electrophoresis – V 2.0


Standard Operating Procedure for Agarose Gel Electrophoresis in Biosimilar R&D

Department Biosimilars
SOP No. SOP/BS/008/2025
Supersedes SOP/BS/008/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a standardized procedure for performing agarose gel electrophoresis to separate, identify, and analyze DNA fragments for plasmid confirmation and molecular biology workflows in biosimilar development.

2. Scope

This SOP applies to all R&D personnel involved in analyzing plasmid DNA, PCR products, and restriction digests through agarose gel electrophoresis within the Biosimilars department.

3. Responsibilities

  • Research Assistant: Prepares gel, loads samples, runs electrophoresis, and documents results.
  • Lab Technician: Maintains electrophoresis equipment and ensures buffer/media quality.
  • QA Representative: Reviews gel documentation for completeness and compliance.
See also  Biosimilars: SOP for Preparation of Competent Cells - V 2.0

4. Accountability

The Head of Molecular Biology is accountable for ensuring that electrophoresis procedures are performed safely, reproducibly, and in accordance with molecular characterization protocols.

5. Procedure

5.1 Materials Required

  • Agarose powder
  • 1X TAE or TBE buffer
  • DNA ladder (100 bp or 1 kb)
  • DNA samples (e.g., plasmids, PCR products)
  • 6X Loading dye
  • DNA stain (e.g., Ethidium Bromide, SYBR Safe)
  • Gel casting tray and comb, electrophoresis tank, power supply

5.2 Gel Preparation

  1. Weigh 1 g agarose for a 1% gel in 100 mL 1X TAE buffer (adjust for volume/concentration as needed).
  2. Microwave gently until agarose dissolves completely (clear solution).
  3. Cool to ~55°C, add DNA stain as per manufacturer’s instructions.
  4. Pour gel into casting tray with comb in place. Allow to solidify (20–30 minutes).

5.3 Sample Preparation

  1. Mix DNA samples (2–5 µL) with 6X loading dye (1 µL).
  2. Centrifuge briefly to collect contents at the bottom of the tube.
See also  Biosimilars: SOP for Protein Expression Profiling - V 2.0

5.4 Gel Electrophoresis

  1. Place the solidified gel into the electrophoresis tank and cover with 1X TAE buffer.
  2. Carefully load samples and DNA ladder into wells.
  3. Connect electrodes (black to negative, red to positive) and run at 80–120 V for 45–60 minutes.

5.5 Visualization and Documentation

  1. Turn off power, remove gel, and visualize under UV or blue-light transilluminator.
  2. Capture gel image with gel documentation system.
  3. Label image with gel number, date, DNA IDs, ladder type, and voltage used.
  4. Attach image to Gel Electrophoresis Log (Annexure-1).

5.6 Cleanup and Waste Disposal

  1. Dispose of used gels and staining agents per biosafety waste guidelines.
  2. Wipe down the tank and tray using 70% ethanol or suitable lab disinfectant.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • TAE: Tris-Acetate-EDTA
  • TBE: Tris-Borate-EDTA
  • QA: Quality Assurance

7. Documents

  1. Gel Electrophoresis Log (Annexure-1)
  2. Gel Documentation Record (Annexure-2)
See also  Biosimilars: SOP for Colony Screening and Expression Analysis - V 2.0

8. References

  • ICH Q5B – Analysis of Expression Constructs
  • WHO Guidelines on Molecular Techniques for DNA Products
  • CDSCO Manual on Molecular Biology Practices

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Gel Electrophoresis Log

Date Gel ID Samples Loaded Ladder Voltage Run Time Operator
03/05/2025 AG-058 pUC19, PCR-A, PCR-B 1 kb Plus 100 V 45 min Sunita Reddy

Annexure-2: Gel Documentation Record

Image File Name Sample IDs Date Captured Remarks
gel_080525.png pUC19, PCR-A 03/05/2025 Sharp bands, expected sizes

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Updated electrophoresis voltage range and gel image tracking Annual update
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Tablets: SOP for Label Printing and Verification for Tablet Packaging – V 2.0
Next Post: BA-BE Studies: SOP for Meal Composition and Timing for Fed Studies – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version